scFv6.C4 DNA vaccine with fragment C of tetanus toxin increases protective immunity against CEA-expressing tumor (Q96126755)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32483214 AND SRC:MED&resulttype=core&format=json

7 June 2020

title

scFv6.C4 DNA vaccine with fragment C of tetanus toxin increases protective immunity against CEA-expressing tumor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32483214 AND SRC:MED&resulttype=core&format=json

7 June 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32483214 AND SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Anjali Geethadevi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32483214 AND SRC:MED&resulttype=core&format=json

7 June 2020

Kapilesh Jadhav

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32483214 AND SRC:MED&resulttype=core&format=json

7 June 2020

Gaurav Kumar

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32483214 AND SRC:MED&resulttype=core&format=json

7 June 2020

publication date

1 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32483214 AND SRC:MED&resulttype=core&format=json

7 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32483214 AND SRC:MED&resulttype=core&format=json

scFv6.C4 DNA vaccine with fragment C of Tetanus toxin increases protective immunity against CEA-expressing tumor

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/S41434-020-0161-9

7 January 2021

A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer

1 reference

https://api.crossref.org/works/10.1038/S41434-020-0161-9

7 January 2021

Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth

1 reference

https://api.crossref.org/works/10.1038/S41434-020-0161-9

7 January 2021

Cancer statistics, 2020

1 reference

https://api.crossref.org/works/10.1038/S41434-020-0161-9

7 January 2021

Preventive DNA vaccination against CEA-expressing tumors with anti-idiotypic scFv6.C4 DNA in CEA-expressing transgenic mice

1 reference

https://api.crossref.org/works/10.1038/S41434-020-0161-9

7 January 2021

Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study

1 reference

https://api.crossref.org/works/10.1038/S41434-020-0161-9

7 January 2021

Anti-idiotype antibody vaccine therapy for cancer

1 reference

https://api.crossref.org/works/10.1038/S41434-020-0161-9

7 January 2021

CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice

1 reference

https://api.crossref.org/works/10.1038/S41434-020-0161-9

7 January 2021

Dendritic cells pulsed with an anti-idiotype antibody mimicking Her-2/neu induced protective antitumor immunity in two lines of Her-2/neu transgenic mice

1 reference

https://api.crossref.org/works/10.1038/S41434-020-0161-9

7 January 2021

Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1038/S41434-020-0161-9

7 January 2021

Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1038/S41434-020-0161-9

7 January 2021

Cancer DNA vaccines: current preclinical and clinical developments and future perspectives

1 reference

https://api.crossref.org/works/10.1038/S41434-020-0161-9

7 January 2021

DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma

1 reference

https://api.crossref.org/works/10.1038/S41434-020-0161-9

7 January 2021

10.1038/S41434-020-0161-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32483214 AND SRC:MED&resulttype=core&format=json

7 June 2020

1 reference